Bioavailability and Pharmacokinetics of Intranasal Hydromorphone in Patients Experiencing Vasomotor Rhinitis

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.24, Iss.11, 2004-01, pp. : 633-639

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics and Bioavailability of Hydromorphone Nasal Spray

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 38, Iss. 3, 2008-09 ,pp. : 191-195

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Intranasal Sumatriptan

By Fuseau E.

Clinical Pharmacokinetics, Vol. 41, Iss. 11, 2002-01 ,pp. : 801-811

Adis International

Access to resources Recommend Favorite

Safety and Tolerability Profiles of Intranasal Antihistamines and Intranasal Corticosteroids in the Treatment of Allergic Rhinitis

By Salib R.J. Howarth P.H.

Drug Safety, Vol. 26, Iss. 12, 2003-01 ,pp. : 863-893

Adis International

Access to resources Recommend Favorite

Intranasal ciclesonide nothing to sneeze at in allergic rhinitis

Inpharma, Vol. 1, Iss. 1435, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Fluticasone Furoate: Intranasal Use in Allergic Rhinitis

By McCormack Paul L. Scott Lesley J.

Drugs, Vol. 67, Iss. 13, 2007-01 ,pp. : 1905-1915

Adis International

Access to resources Recommend Favorite